Mesirow Financial Investment Management Equity & Fixed Income Supernus Pharmaceuticals, Inc. Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$25.33 - $34.25 $481,523 - $651,092	19,010 Added 5.0%	398,885 $11.5 Million
Q1 2022 May 09, 2022	SELL	$28.51 - $32.9 $2,851 - $3,290	-100 Reduced 0.03%	379,875 $12.3 Million
Q4 2021 Feb 07, 2022	BUY	$26.37 - $34.22 $1.29 Million - $1.67 Million	48,835 Added 14.75%	379,975 $11.1 Million
Q3 2021 Nov 04, 2021	BUY	$23.54 - $31.39 $7.8 Million - $10.4 Million	331,140 New	331,140 $8.83 Million
Q2 2019 Jul 30, 2019	SELL	$29.96 - $38.87 $4.9 Million - $6.36 Million	-163,691 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$32.77 - $41.99 $1.53 Million - $1.97 Million	46,805 Added 40.04%	163,691 $5.74 Million
Q4 2018 Feb 05, 2019	SELL	$30.84 - $49.51 $3.93 Million - $6.31 Million	-127,470 Reduced 52.17%	116,886 $3.88 Million
Q3 2018 Oct 29, 2018	SELL	$42.7 - $56.55 $514,321 - $681,144	-12,045 Reduced 4.7%	244,356 $12.3 Million
Q2 2018 Aug 02, 2018	SELL	$44.1 - $59.85 $1.13 Million - $1.54 Million	-25,655 Reduced 9.1%	256,401 $15.3 Million
Q1 2018 May 09, 2018	SELL	$37.15 - $46.9 $3.54 Million - $4.47 Million	-95,405 Reduced 25.28%	282,056 $12.9 Million
Q4 2017 Jan 30, 2018	BUY	$36.4 - $42.6 $819,218 - $958,755	22,506 Added 6.34%	377,461 $15 Million
Q3 2017 Oct 30, 2017	BUY	$36.75 - $49.65 $13 Million - $17.6 Million	354,955	354,955 $14.2 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$376 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$221 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$184 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$104 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$95.1 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account